StockMarketWire.com - PureTech Health said affiliate Gelesis had received marketing clearance from the FDA for a weight management product.

The orally-administered hydrogel was designed to absorb water and increase the volume and elasticity of the stomach and small intestine contents to help people feel full.

Gelesis planned to initiate a targeted US launch in the second half of 2019 and anticipated that the product would be broadly available by prescription in the US in 2020.


At 8:26am: [LON:PRTC] PureTech Health Plc share price was +12.25p at 175.75p



Story provided by StockMarketWire.com